This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2021 Mar 27;397(10280):1182.

doi: 10.1016/S0140-6736(21)00669-3.

Department of Error

No authors listed

PMID: 33773628
DOI: 10.1016/S0140-6736(21)00669-3

Published Erratum

Department of Error

No authors listed. Lancet. 2021.

. 2021 Mar 27;397(10280):1182.

doi: 10.1016/S0140-6736(21)00669-3.

PMID: 33773628
DOI: 10.1016/S0140-6736(21)00669-3

No abstract available

PubMed Disclaimer

Erratum for

Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial.
Gordon KB, Foley P, Krueger JG, Pinter A, Reich K, Vender R, Vanvoorden V, Madden C, White K, Cioffi C, Blauvelt A. Gordon KB, et al. Lancet. 2021 Feb 6;397(10273):475-486. doi: 10.1016/S0140-6736(21)00126-4. Lancet. 2021. PMID: 33549192 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations